The notch receptors: multi-regulators of PAH development

26 August 2021

A PVRI 2021 Digital webinar

Presentations 

  • Role of notch1 in experimental pulmonary hypertension Ralph Schermuly
  • Notch-BMPR interactions in endothelium in PAH Marlene Rabinovitch
  • Notch3 is a driver and biomarker for PAH Patricia Thistlethwaite 
  • Notch3 lineage and pulmonary vasculopathy Maya Kumar 

Speakers & moderators

Ralph Schermuly, Justus Liebig University Giessen, Germany
Marlene Rabinovitch, Stanford University, USA
Patricia Thistlethwaite, University of California San Diego, USA
Maya Kumar, Stanford University, USA
Share:

Other materials on this topic

25 February 2021

Keynote lecture session 2021

  • Health and wearables: Is this the dawn of a new age for cardiovascular medicine? Martin Cowie
  • Professor Sheila Glennis Haworth Memorial Lecture - Translational Research on PAH, Jason Yuan 
  • Biomarker Analysis of the PULSAR Study: An Ongoing Phase 2, Double-Blind, Placebo-Controlled, Randomized Study to Compare the Efficacy and Safety of Sotatercept (ACE-011) Versus Placebo When Added to Standard of Care for the Treatment of PAH, Marc Humbert
  • Switching from PDE5i to riociguat in patients with PAH: The REPLACE study, Raymond Benza
  • A diagnostic miRNA signature for PAH using a consensus machine learning approach (Rupert Swift Award 2021), Niamh Errington
PVRI Digital Webinar Series
Additional comments are available to members. Login or register to become a member today
RegisterorLogin to view